AU7922694A - Dipeptide boronic acid inhibitors of trypsin-like enzymes - Google Patents

Dipeptide boronic acid inhibitors of trypsin-like enzymes

Info

Publication number
AU7922694A
AU7922694A AU79226/94A AU7922694A AU7922694A AU 7922694 A AU7922694 A AU 7922694A AU 79226/94 A AU79226/94 A AU 79226/94A AU 7922694 A AU7922694 A AU 7922694A AU 7922694 A AU7922694 A AU 7922694A
Authority
AU
Australia
Prior art keywords
trypsin
enzymes
boronic acid
acid inhibitors
dipeptide boronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79226/94A
Inventor
Matthew Mark Abelman
Eugene Cruz Amparo
Joseph Cacciola
John Matthew Fevig
Charles Adrian Kettner
Gregory James Pacofsky
Chia-Lin J Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/139,444 external-priority patent/US5462964A/en
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Publication of AU7922694A publication Critical patent/AU7922694A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU79226/94A 1993-10-07 1994-10-06 Dipeptide boronic acid inhibitors of trypsin-like enzymes Abandoned AU7922694A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US139444 1980-04-11
US13325293A 1993-10-07 1993-10-07
US133252 1993-10-07
US08/139,444 US5462964A (en) 1993-10-20 1993-10-20 Dipeptide boronic acid inhibitors of trypsin-like enzymes
PCT/US1994/011048 WO1995009858A1 (en) 1993-10-07 1994-10-06 Dipeptide boronic acid inhibitors of trypsin-like enzymes

Publications (1)

Publication Number Publication Date
AU7922694A true AU7922694A (en) 1995-05-01

Family

ID=26831205

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79226/94A Abandoned AU7922694A (en) 1993-10-07 1994-10-06 Dipeptide boronic acid inhibitors of trypsin-like enzymes

Country Status (3)

Country Link
AU (1) AU7922694A (en)
IL (1) IL111176A0 (en)
WO (1) WO1995009858A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
CA2143533A1 (en) * 1994-03-04 1995-09-05 Kenneth D. Kurz Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5693617A (en) * 1994-03-15 1997-12-02 Proscript, Inc. Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US20050288253A1 (en) 2002-09-09 2005-12-29 Trigen Limited Boronic acid salts
KR20050057294A (en) * 2002-09-09 2005-06-16 트라이젠 리미티드 Boronic acid salts and their use in the treatment of thrombosis
CN1729174B (en) * 2002-12-20 2015-10-21 西巴特殊化学品控股有限公司 The synthesis of amine and the intermediate for the synthesis of amine
US7417040B2 (en) 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7378426B2 (en) 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
GB0505969D0 (en) 2005-03-23 2005-04-27 Novartis Ag Organic compounds
BRPI0620736A2 (en) 2005-12-30 2011-12-20 Novartis Ag organic compounds
ES2541107T3 (en) 2007-06-25 2015-07-16 Novartis Ag N5- (2-ethoxyethyl) -N3- (2-pyridinyl) -3,5-piperidindicarboxamide derivatives for use as renin inhibitors
KR102595723B1 (en) 2016-06-21 2023-10-27 오리온 옵탈몰로지 엘엘씨 Heterocyclic Prolinamide Derivatives
JP7164521B2 (en) 2016-06-21 2022-11-01 オリオン・オフサルモロジー・エルエルシー carbocyclic prolinamide derivatives
CA3183740A1 (en) 2020-06-10 2021-12-16 Aligos Therapeutics, Inc. Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
KR20240035513A (en) 2021-07-09 2024-03-15 알리고스 테라퓨틱스 인코포레이티드 antiviral compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
GB9017694D0 (en) * 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry
GB9024129D0 (en) * 1990-11-06 1990-12-19 Thrombosis Research Trust Inhibitors and substrates of thrombin
EP0503203A1 (en) * 1991-03-15 1992-09-16 Merrell Dow Pharmaceuticals Inc. Novel thrombin inhibitors

Also Published As

Publication number Publication date
WO1995009858A1 (en) 1995-04-13
IL111176A0 (en) 1994-12-29

Similar Documents

Publication Publication Date Title
AU7922694A (en) Dipeptide boronic acid inhibitors of trypsin-like enzymes
AU7966494A (en) Electrophilic peptide analogs as inhibitors of trypsin-like enzymes
AU1733288A (en) Peptide boronic acid inhibitors of trypsin-like proteases
AU4640496A (en) Boronic acid and ester inhibitors of thrombin
AU5533094A (en) Enzyme inhibitors
AU3967195A (en) Amidino and guanidino substituted inhibitors of trypsin-like enzymes
AU4980697A (en) Ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloprote inase and tace inhibitors
AU4153197A (en) Phosphinic acid amides as matrix metalloprotease inhibitors
PL323710A1 (en) Reversible inhibitors of cysteinic protease
AU3193489A (en) Renin inhibitors containing alpha-heteroatom amino acids
PL314838A1 (en) Inhibitors of bp-iv-serine protease
AU3972697A (en) Inhibitors of cysteine protease
AU6897094A (en) Identification and use of protease inhibitors
AU5687396A (en) N-aroylamino acid amides as endothelin inhibitors
AU5665396A (en) Novel hydroxamic acid and amino-carboxylate compounds as met alloprotease and tnf inhibitors
AU4422096A (en) Hydroxamic acid-containing inhibitors of matrix metalloproteases
AU3479593A (en) Peptidyl derivatives as inhibitors of interleukin-1beta converting enzyme
AU9663798A (en) Heteroaryl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
AU6703894A (en) Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
AU5913190A (en) Peptidyl aminodiol renin inhibitors
AU2277597A (en) New inhibitors of sh2-mediated processes
AU9624398A (en) Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors
AU4672996A (en) Serine protease inhibitors
AU2938997A (en) Subsituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
AU2126895A (en) Parasite enzyme inhibitors and substrate analogs